Bunge

Archer-Daniels-Midland

Grain Industry Looks to 2026 for a More Stable Year After Turbulent 2021

Bunge Global Exceeds Expectations with Adjusted Earnings, Viterra Synergies, and Integration Progress.

邦吉

Bunge's 15min chart triggers Bollinger Bands Narrowing, KDJ Death Cross alert.

Jpmorgan Chase

JPMorgan Maintains Overweight on Bunge, Raises PT to $130 from $117

UBS Group

UBS Raises Bunge's PT to $145 from $108, Maintains Buy Rating

Catalyst<ul> <li>Most analysts rate BG Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a weak state and we need to pay attention to the risk of decline.</li> <li>Bearish signals are obviously dominant (2 bearish vs 0 bullish).</li></ul>

Key Factors

Bunge reported Q4 2025 adjusted EPS of $1.99, exceeding expectations and driven by earnings growth across all segments despite non-recurring charges. Bunge forecasts 2026 adjusted EPS of $7.50 to $8, citing accelerated synergy gains from its Viterra integration. Bunge's Q4 2025 net income declined to $95 million from $602 million in Q4 2024 due to a global grain glut and trade tensions with China. JPMorgan raised Bunge's price target to $130 from $117, maintaining an Overweight rating. UBS increased Bunge's price target to $145 from $108 and maintained a Buy rating.

Recent Updates

BG News